Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

85 results found in London

Sort by:
Showing 21 - 30 of 85 results
Haematology
38 years of experience

Professor John Pasi Consultant Haematologist specialising in haemostasis and thrombosis, with a particular clinical interest in thrombosis due to an inherited condition or resulting from age-related and chronic disease-related changes during later life. He also treats patients with a variety of bleeding problems including genetic conditions such as von Willebrand disease and haemophilia.

Professor Pasi graduated in medicine from the University of Birmingham in 1983 completing specialist training in haematology at Birmingham Children’s Hospital. He was awarded a PhD for his research and in 1993 was appointed as Consultant Haematologist and Honorary Senior Lecturer at the Royal Free Hospital and School of Medicine, where he remained until 1999. He was then appointed Professor of Haematology at the University of Leicester, as well as Head of Haematology Services at the University Hospitals of Leicester NHS Trust.

Outside his clinical work, he is keen to promote good practice in haematology, helping to develop various national guidelines concerned with how haemostatic and thrombotic disorders should be optimally treated.


Diseases, Medical Tests and Treatments

Treatment of:

  • Blood coagulation
  • Thrombosi
  • Bleeding disorders
  • Venous thromboembolism (DVT and PE)
  • Anticoagulation
  • Haemostasis
  • Thrombosis
  • Inherited clotting disorders
  • Von Willebrand disease
  • Haemophilia
  • Pulmonary thrombo-embolism
  • Bleeding disorders
Read more
Oncology
17 years of experience
Medical Oncology, Urological Oncology

Mr Georgios Antoniou is a consultant medical oncologist based in Berkshire and Middlesex, UK. He specialises in urology and has over 16 years of medical experience and over 9 years of specialist experience in medical oncology.

Dr Antoniou completed his Medical Degree at the Aristotle University of Thessaloniki in 2005. He then went on to complete a Master’s in Clinical, Laboratory Science, Research and Allied Professionals at Harvard Medical School and a Master’s in Cancer Therapeutics at the University of London. He also completed a PhD at National and Kapodistrian University of Athens, Greece. 

After receiving his medical degree, Dr Antoniou completed several years of training in medical oncology and became both a Clinical and Research Fellow in NHS Trusts and oncology centres in the United States and Cyprus.

He currently practices as a Consultant in medical oncology at GenesisCare Windsor, Berkshire. Here, he treats patients with cancer, particularly urological cancers however he has a wealth of experience in other cancers such as breast cancer and gynaecological cancers.

Dr Antoniou has special interests in systemic treatments, targeted therapies, immunotherapy and personalised medicine. He is also a member of The Institute of Cancer Research.

Read more
Pain Management
Recommended by 1 specialist
29 years of experience
Spinal Medicine

Dr Joseph Azzopardi is a Consultant in Pain Medicine & Anaesthesia at Guy's and St. Thomas' Hospital. Graduating from the University of Malta in 1993, he received anaesthetic and pain training in Dublin and London. In 2000, he was a visiting fellow in Regional Anaesthesia in Uppsala, Sweden. Subsequently in 2002 to 2004, he acquired advanced specialist training in Pain Medicine in Sydney and Adelaide where he developed his interests in interventional pain management, neuromodulation and cancer pain.

Dr Azzopardi is also a Fellow of the Royal College of Anaesthetists UK. He was awarded the Fellowship of the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists in 2004 and is furthermore a Foundation Fellow of the Faculty of Pain Medicine of the Royal College of Anaesthetists.

He dedicates a significant part of his clinical time to managing Cancer Pain and has been actively involved with the development of Multidisciplinary Integrated Cancer Pain Services at Guys and St.Thomas' Foundation Trust. He also contributes to the Acute Pain Service in Guy’s & St Thomas’ Hospital.

Beyond his clinical interests, Dr Azzopardi also provides Medico-Legal specialist reports and accepts instructions for defendant and claimant personal injury. He has a keen interest in Medical Education and sits on the London Deanery Pain Training Advisory Group Committee. Until only recently, he was the Educational Supervisor for Advanced Pain Training in Guy’s & St Thomas’ Hospital.

His Anaesthetic interests include Difficult Airway Anaesthesia, Regional Anaesthesia and Anaesthesia in the Developing World. To this extent, he has been the Lead anaesthetist on numerous charity missions in Ethiopia with Facing Africa and Project Harar. In addition to this, he is actively involved in postgraduate education, medical simulation and is a clinical supervisor for higher specialist training in Pain Medicine.

Read more
Oncology
21 years of experience
Bowel Cancer, Breast Cancer, Clinical Oncology + 10more

Dr Tom Richards is a consultant clinical oncologist specialising in the treatment of gastrointestinal (GI) and breast cancers. He is the clinical lead of the GI and breast cancer radiotherapy units at University College London NHS Hospital (UCLH) and honorary consultant in Clinical Oncology at The Whittington NHS Hospital. Prior to his appointment at UCLH, he was Clinical Oncology consultant in the GI and breast units at St Bartholomew's and The Royal London NHS Hospitals.

He is an experienced oncologist treating oesophagus, stomach, liver, pancreaticobiliary, colorectal and breast cancers. His specialist expertise is the delivery of radiotherapy, chemotherapy and biological targeted drugs for cancers at these sites. His particular interest is in technical radiotherapy treatments using cyberknife and intensity-modulated radiotherapy and motion management techniques using 4D-CT radiotherapy planning, deep inspiratory breath-hold and image-guided radiotherapy.

After graduation from Imperial College School of Medicine in London, his subsequent general internal medicine training was at King's College Hospital, London. He undertook specialist oncology training at St Bartholomew's and The Royal Marsden Hospitals in London. In 2015 he was awarded a PhD from the University of London for clinical and translation research performed at The Institute of Cancer Research, King's College London and The Royal Marsden Hospital. He studied the mechanisms by which therapeutic radiation affects normal tissues and strategies to detect and reduce late toxicity after curative treatment. He was awarded the Johnson and Johnson clinical research prize in 2012 for work contributing to his PhD.

He is a fellow of the Royal College of Radiologists and a member of The Royal College of Physicians, ESMO and ESTRO. He has spoken and chaired sessions at numerous national and international meetings. He is course tutor and examiner for the Institute of Cancer research MSc course and is the local principal investigator for several GI cancer clinical trials. Dr Richards is passionate to improve cancer outcomes, develop clinical research and deliver innovative multi-modality cancer treatments.


Diseases, Medical Tests and Treatments

  • Radiotherapy
  • Chemotherapy
  • SABR/Cyberknife
  • Intensity-modulated radiotherapy
  • SIRT (internal liver-directed radiotherapy)
  • Breast cancer
  • Colon cancer
  • Rectal cancer
  • Anal cancer
  • Oesophageal cancer
  • Liver cancer
  • Pancreatico-biliary cancer


Read more

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Oncology
Recommended by 1 specialist
33 years of experience
Clinical Oncology

Lucy Brazil is a Consultant Oncologist who has been with Guy’s and St Thomas’ and King’s College Hospitals since 2005. In 2007, she was awarded an MD for research into breast cancer genetics at the Institute of Cancer Research and Breakthrough Breast Cancer.

Dr Brazil trained in oncology at the Royal Marsden Hospital and Guy’s and St Thomas’ Hospitals. Her specialist interests include neuro-oncology particularly high grade glioblastoma multiforme and low grade glioma including oligodendroglioma and spinal tumours and breast cancer including management of brain metastases. Dr Brazil has expertise in radiotherapy both standard conformal and stereotactic techniques and including Cyberknife, Rapid-Arc and IMRT. She also oversees chemotherapy and endocrine treatments.

Dr Brazil is a member of the NCI National Cancer Institute Brain Tumour Clinical Studies Group and the EORTC European Organisation of Research and Treatment of Cancer Brain Tumour Group. She is chief investigator for the CODEL brain tumour study using chemotherapy and radiotherapy for grade 3 gliomas, chairman of the brain-tumour palliative care sub-group and neuro-oncology research lead at Guy's and St Thomas' in addition to being systemic chemotherapy neuro-oncology lead at the hospital.

 


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Palliative Care
  • Brain Cancer
  • Breast Cancer
  • Neuro-oncology
Read more
Oncology
Offers video consultation
28 years of experience
Breast Cancer, Clinical Oncology, Medical Oncology

Dr Hadaki is an experienced Consultant Oncologist who treats all stages of breast cancer.

He completed his specialist oncology training at Addenbrooke’s Teaching Hospital which has strong affiliations to the University of Cambridge. During his training, he completed the Royal College of Radiologist membership exam to proudly become one of its fellowships.

Dr Hadaki has been practising as a consultant since 2012 and has a very successful private practise in addition to his large well-established NHS practice.

Dr Hadaki is skillfully able to combine (where appropriate) the following treatment modalities to offer a complete and state of the art personalised cancer treatment service:

  • Chemotherapy
  • External beam radiotherapy (including IMRT and IGRT)
  • Biological and targeted therapies
  • Immunotherapies
  • Stereotactic radiotherapy (SBRT, SABR, Cyberknife)
  • Next-generation sequencing and molecular analysis of tumours
  • Chemotherapy sensitivity testing
  • Access to clinical trials
  • Access to local ablative therapies (radiofrequency ablation, microwave ablation)
  • Access to alternative therapies
  • Access to palliative care services

Dr Hadaki also works with some of the most skilled surgeons in the country. All treatment plans are discussed at multidisciplinary team meetings.

Dr Hadaki is registered and compliant with the majority of private medical insurers including BUPA, BUPA International, AXA, Aviva, Vitality, WPA and others.

Dr Hadaki is able to treat international and self-paying patients. Embassy sponsored patients must have a letter of guarantee before any consultation or commencing treatment.

Self-paying patients should contact us directly for a quotation.


Diseases, Medical Tests and Treatments

  • Breast Cancer
  • Lung Cancer
  • Chemotherapy
  • Immunotherapy
  • Radiotherapy
  • Stereotactic ablative radiotherapy (SABR)
  • Oncology
  • Breast Cancer


Read more
Oncology
22 years of experience
Medical Oncology

I am a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London Hospitals NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Insitute. I treat oesophageal, stomach, small bowel, colorectal and hepatobiliary cancers, as well as cancers of unknown primary. I am the UCLH Clinical Lead for the Cancer of Unknown Primary (CUP) Service and the Acute Oncology Service.


My research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary, with focus on clinical trials and translational research of these cancers. I am Chief Investigator or Principal Investigator for a number of  GI or CUP immuno-oncology Phase 2 and 3 trials, including KEYNOTE 177, KEYNOTE 859, KEYNOTE 811, KEYNOTE 975,  VESTIGE, POLEM and CUPISCO.


I am Chair of the NCRI MUO-CUP Workstream as part of the Living With and Beyond Cancer CSG, and a member of the NCRI Colorectal Advanced and Adjuvant Disease Subgroup. I am the Principal Investigator of the UCL-UCLH GI + CUP Cancer Translational Research Biobank and a collaborator with the GI Oncology and CUP subgroups at the UCL Cancer Institute and Francis Crick Institute. I am a member of ASCO, ESMO and the Association of Cancer Physicans (UK).


I strongly believe in clinicians being educators and enjoy teaching oncology to UCL medical students, oncology and non-oncology junior trainees. I also give talks nationally and abroad at conferences and other hospitals to share best practice and future perspectives in the fields of GI oncology research, CUP, immunotherapy and novel trial designs.


To make an appointment or enquiry please contact my secretary Alanna Sarwar on asarwar@theloc.com or +44207 317 2659.


Diseases, Medical Tests and Treatments
  • Gastrointestinal Oncology - oesophageal, stomach, hepatobiliary and bowel cancers
  • Cancer of Unknown Primary
  • Acute Oncology
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Clinical Trials
  • Immunotherapy
  • Gastrointestinal Oncology Research 
  • Cancer of Unknown Primary Research 
  • Molecular Profiling with solid and liquid biopsies
  • Biomarker Driven Clinical Trial Design and Implementation
Read more

Dr Peter Harper trained at University College and University College Hospital (MB BS 1970) and has been a leading consultant at Guy's and St Thomas Hospital for over 25 years. He is both an accredited physician and a medical oncologist. One of the four founder partners of the London Oncology Clinic, his vision was of a clinic dedicated solely to cancer treatment offering the highest international standards of care in a state-of-the-art supportive environment, also providing the support including all the ancillary care required by patients and their families.

Author of more than 400 papers and chapters in peer-reviewed publications, he is acknowledged globally for his work in researching new drugs and developing improved forms of cancer treatment. He has been the chair, or has been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications and is currently a member of eight pharmaceutical company advisory boards and is a member of sixteen professional bodies from around the world, including board membership of a committee of the American Society of Clinical Oncologists (ASCO).

In 2002 he was awarded the prestigious Cino del Duca Medal in 2004 in recognition of his work in developing new anti-cancer and vaccine therapies. For his role in advising the French Government in strategic cancer care (Board Member French National Cancer Institute), he was appointed a Chevalier of the Legion D'Honneur, a rare distinction for a foreign national. He remains on the board of INCA, the strategic committee for cancer treatment in France, and is currently the Chairman of the Toulouse Cancer Centre and holds the Medaille D'Or of that city.


Diseases, Medical Tests and Treatments
  • Chemotherapy of solid tumours
  • Gynaecological cancers
  • Gastrointestinal cancers
  • Breast cancer
  • Lung cancer
  • Urological cancers
  • Chemotherapy of solid tumours
  • Gynaecological cancers
  • Gastrointestinal cancers
  • Breast cancer
  • Lung cancer
  • Urological cancers
Read more
Oncology
25 years of experience
Advanced Melanoma, Medical Oncology, Renal Cancer + 1more

Dr Paul Nathan is an internationally renowned and well-respected Consultant Medical Oncologist with HCA Healthcare at LOC, The Harley Street Clinic, and The Wellington Hospital. His NHS practice is based at Mount Vernon Cancer Centre and UCLH. Dr Nathan’s clinical interests include melanoma of the skin, eye, and internal organs; kidney cancer (renal cell carcinoma), and rare skin cancers including Merkel cell carcinoma.

He originally trained in cancer immunology as a scientist, and following his Ph.D. and post-doctoral position in Pittsburgh, he ran a tumor immunology laboratory in the pharmaceutical industry. He then pursued clinical studies at Cambridge and UCL.

Dr Nathan has been a Consultant Medical Oncologist for nearly 20 years. He remains heavily involved in research and is the lead investigator for many clinical trials, particularly in the field of immunotherapy and targeted therapies. Most recently he has led the development of tebentafusp, the first drug proven to improve survival in advanced uveal melanoma. Dr Nathan has published over 100 papers, many of which are in the world’s leading medical journals, and has contributed to a number of medical textbooks. He is the Chair of the UK Uveal Melanoma Guidelines group and the UK Lead for Uveal Melanoma at the International Rare Cancer Initiative. He also leads the melanoma systemic therapies for the European cancer organisation’s (EORTC) melanoma group. Previously, Dr Nathan chaired the NCRI renal cancer clinical studies group. 

 


Diseases, Medical Tests and Treatments

  • Immunotherapy
  • Chemotherapy
  • Urological Cancer
  • Kidney Cancer
  • Renal Cancer
  • Skin Cancer
  • Melanoma
Read more